Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]

Susana M. Campos, William E. Brady, Katherine M. Moxley, Roisin E. O'Cearbhaill, Paula S. Lee, Paul A. DiSilvestro, Jacob Rotmensch, Peter G. Rose, Premal H. Thaker, David M. O'Malley, Parviz Hanjani, Rosemary E. Zuna, Martee L. Hensley

Research output: Contribution to journalComment/debate

1 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]'. Together they form a unique fingerprint.